Boston Scientific (BSX) is discontinuing worldwide sales of Acurate Neo2 & Acurate Prime Aortic valve systems; no longer pursuing FDA approval for Acurate approval in other geographies; Does not reaffirm guidance
- Not reaffirming Q2 and FY 25 GAAP EPS guidance issued on April 23rd.
28 May 2025 - 12:50- Equities- Source: Newswires
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts